Horan Securities, Inc. Novartis Ag Transaction History

Horan Securities, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 18, 2023	SELL	$80.03 - $92.81 $400 - $464	-5 Reduced 3.85%	125 $11,000
Q4 2022 Jan 17, 2023	BUY	$75.55 - $92.52 $377 - $462	5 Added 4.0%	130 $0
Q3 2022 Oct 12, 2022	SELL	$74.61 - $87.26 $4,028 - $4,712	-54 Reduced 30.17%	125 $10,000
Q2 2022 Jul 19, 2022	BUY	$80.52 - $93.75 $4,348 - $5,062	54 Added 43.2%	179 $15,000
Q3 2020 Nov 04, 2020	SELL	$82.14 - $91.0 $3,942 - $4,368	-48 Reduced 27.75%	125 $11,000
Q2 2020 Aug 11, 2020	BUY	$80.93 - $91.1 $3,884 - $4,372	48 Added 38.4%	173 $15,000
Q1 2020 May 05, 2020	BUY	$70.67 - $99.01 $8,833 - $12,376	125 New	125 $10,000
Q4 2019 Feb 05, 2020	SELL	$84.35 - $95.37 $10,543 - $11,921	-125 Closed	0 $0
Q2 2018 Jul 23, 2018	BUY	$64.91 - $73.36 $8,113 - $9,170	125 New	125 $10,000

1,437

131M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $212B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Horan Securities, Inc., based on Form 13F filings with the SEC.

Stay updated on Horan Securities, Inc. with notifications on news.